Hearten Medical MyoTech Cardiac System IDE Submission Imminent
This article was originally published in The Gray Sheet
Executive Summary
Hearten Medical will submit an investigational device exemption application to FDA in early December for a pivotal U.S. clinical trial of its radiofrequency-based MyoTech cardiac restoration system.